Zobrazeno 1 - 10
of 339
pro vyhledávání: '"Gaeta, GB"'
Autor:
Colombo GL, Cammà C, Attili AF, Ganga R, Gaeta GB, Brancaccio G, Franzini JM, Volpe M, Turchetti G
Publikováno v:
Therapeutics and Clinical Risk Management, Vol 2015, Iss default, Pp 1603-1612 (2015)
Giorgio Lorenzo Colombo,1 Calogero Cammà,2 Adolfo Francesco Attili,3 Roberto Ganga,4 Giovanni Battista Gaeta,5 Giuseppina Brancaccio,5 Jean Marie Franzini,6 Marco Volpe,6 Giuseppe Turchetti7 1Department of Drug Sciences, University of Pavia, Pavia,
Externí odkaz:
https://doaj.org/article/66afc3f9da3e4d8a92404ef24416dbc6
Autor:
Aghemo, A, Alberti, A, Andreone, P, Angelico, M, Brunetto, Mr, Chessa, L, Ciancio, A, Craxì, A, Gaeta, Gb, Galli, M, Gasbarrini, A, Giorgini, A, Grilli, E, Lampertico, P, Lichtner, M, Milella, M, Morisco, F, Persico, M, Pirisi, M, Puoti, M, Raimondo, G, Romano, A, Russello, M, Sangiovanni, V, Schiavini, M, Serviddio, G, Villa, E, Vinci, M, De Michina, A, Gallinaro, V, Gualberti, G, Roscini, As, Zignego, Al, MARS Study Group
Background and Aims The MARS post-marketing, observational study evaluates glecaprevir/pibrentasvir in a large population of Italian patients who are infected with HCV. Patients and Methods Achievement of SVR12 was the primary endpoint in the overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9628a0310f1dd8b4b1fff6211c29cacd
http://hdl.handle.net/10447/535598
http://hdl.handle.net/10447/535598
Autor:
Sebastiani, M, Milazzo, L, Atzeni, F, Vacchi, C, Manfredi, A, Quartuccio, L, Scire, C, Gaeta, GB, Lapadula, G, Armignacco, O, Tavio, M, D'Angelo, S, Meroni, P, Bazzichi, L, Grassi, W, Mathieu, A, Mastroianni, C, Sagnelli, E, Santantonio, T, Uberti Foppa, C, Puoti, M, Sarmati, L, Airo, P, Epis, OM, Scrivo, R, Gargiulo, M, Riva, A, Ciancio, G, Zehender, G, Taliani, G, Meroni, L, Sollima, S, Sarzi-Puttini, P, Galli, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::f66dc7f29485d6dcd41836f1df319324
Autor:
Pisaturo M, Minichini C, Starace M, Caroprese M, Macera M, Brancaccio G, De Pascalis S, Santonicola A, Galeota Lanza A, Zampino R, Cotticelli G, Sagnelli E, Gaeta GB, Coppola N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::08134aacca332730cfcfb2aceb0cd9a8
http://hdl.handle.net/11591/401105
http://hdl.handle.net/11591/401105
Autor:
Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Adinolfi LE, Claar E, Precone D, Stornaiuolo G, Stanzione M, Ascione T, Caroprese M, Zampino R, Parrilli G, Gentile I, Brancaccio G, Iovinella V, Martini S, Masarone M, Fontanella L, Masiello A, Sagnelli E, Punzi R, Salomone Megna A, Santoro R, Gaeta GB, Coppola N., Zampino R. Parrilli G, Masarone M.
The study characterized the virological patterns and the resistance-associated substitutions (RASs) in patients with failure to IFN-free regimens enrolled in the real-life setting. All 87 consecutive HCV patients with failed IFN-free regimens, observ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3b943650a5856e781915ef9711c51b
http://hdl.handle.net/11577/3255063
http://hdl.handle.net/11577/3255063
Autor:
Coppola, N, De Pascalis, S, Messina, V, Di Caprio, G, Martini, S, de Stefano, G, Starace, M, Stornaiuolo, G, Sangiovanni, V, Stanzione, M, Zampino, R, Calo, F, Rinaldi, L, Persico, M, Federico, A, Gaeta, Gb, Filippini, P, BUONOMO, ANTONIO RICCARDO, BORGIA, GUGLIELMO, GENTILE, Ivan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::b43a776386b674ab0ecb0f990e6e8d8d
http://hdl.handle.net/11588/679050
http://hdl.handle.net/11588/679050
Autor:
Macera M, Stanzione M, Messina V, D'Adamo G, Sangiovanni V, Mioglioresi L, Fontanella L, De Pascalis S, Stornaiuolo G, Galeota Lanza A, Ascione T, Sagnelli E, Gentile I, Piai G, Gaeta GB, Coppola N.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::2c708e9349e5d50c1d297813df885a0d
http://hdl.handle.net/11591/386620
http://hdl.handle.net/11591/386620
Autor:
Martini, Silvia, Donato, Maria Francesca, Mazzarelli, Chiara, Rendina, Maria, Visco-Comandini, Ubaldo, Filì, Daniela, Gianstefani, Alice, Fagiuoli, Stefano, Melazzini, Mario, Montilla, Simona, Pani, Luca, Petraglia, Sandra, Russo, Pierluigi, Trotta, Maria Paola, Carrai, Paola, Caraceni, Paolo, ITACOPS study group, Angeli, P, Ballardini, G, Bernabucci, V, Bhoori, S, Burra, P, Civolani, A, D'Offizi, G, Felder, M, Gaeta, Gb, Ganga, R, Ginanni Corradini, S, Iemmolo, Rm, Lenci, I, Lionetti, R, Montalbano, M, Morelli, Mc, Picciotto, A, Sapere, C, Serviddio, G, Tamè, M, Verucchi, G, Zignego, A. L.
Background & aims This study aimed to assess the real-life clinical and virological outcomes of HCV waitlisted patients for liver transplantation (LT) who received sofosbuvir/ribavirin (SOF/R) within the Italian compassionate use program. Methods Cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04fd8f1b5c8923a5377525f4e876658f
http://hdl.handle.net/11567/938745
http://hdl.handle.net/11567/938745